Clinical Research Directory
Browse clinical research sites, groups, and studies.
Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants
Sponsor: The University of Texas Health Science Center at San Antonio
Summary
A comprehensive analysis of the impact of exogenous enteral DHA and ARA supplementation on lipid metabolism including the production of downstream derived mediators and how this impacts important biological pathways such as metabolism, inflammation, and organogenic factors.
Official title: Metabolic Mechanisms Induced by Enteral Docosahexaenoic Acid (DHA) and Arachidonic Acid (ARA) Supplementation in Preterm Infants
Key Details
Gender
All
Age Range
Any - 36 Weeks
Study Type
INTERVENTIONAL
Enrollment
328
Start Date
2023-03-09
Completion Date
2028-04
Last Updated
2025-09-24
Healthy Volunteers
No
Conditions
Interventions
Enfamil® DHA & ARA Supplement for Special Dietary Use
Dosage: 60 mg/kg/day of DHA and 120 mg/kg/day of ARA. Route of administration: enteral tube or by oral syringe
Locations (7)
University of California, Los Angeles (UCLA)
Los Angeles, California, United States
Yale New Haven Hospital
New Haven, Connecticut, United States
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States
Northwestern University
Chicago, Illinois, United States
Weill Cornell Medicine
New York, New York, United States
University Health System
San Antonio, Texas, United States
University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States